Sun Pharmaceutical Industries Limited at its board meeting held on May 22, 2024, appointed Mr. Dilip Shanghvi, Managing Director of the Company as the Chairman of the Board with immediate effect.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,467 INR | -0.25% |
|
-3.22% | +16.50% |
06-21 | Japanese Stocks End Little Changed After Three-Day Winning Streak on Inflation and Yen Woes | MT |
06-21 | Takeda gives Sun Pharma, Cipla rights to commercialize gastro drug in India | RE |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.50% | 42.12B | |
+20.78% | 21.72B | |
+21.14% | 15.75B | |
+23.69% | 14.89B | |
+57.44% | 13.06B | |
-0.05% | 6.79B | |
-14.94% | 6.3B | |
+20.03% | 6.05B | |
-8.87% | 5.73B | |
+6.29% | 4.58B |
- Stock Market
- Equities
- SUNPHARMA Stock
- News Sun Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Limited Appoints Dilip Shanghvi as Chairman of Board